[Congressional Record (Bound Edition), Volume 151 (2005), Part 3]
[House]
[Page 4180]
[From the U.S. Government Publishing Office, www.gpo.gov]




                   STRENGTHENING HEMOPHILIA RESEARCH

  (Mr. PRICE of Georgia asked and was given permission to address the 
House for 1 minute and to revise and extend his remarks.)
  Mr. PRICE of Georgia. Mr. Speaker, as a physician and an orthopedic 
surgeon for over 20 years, I have seen hemophilia countless times. What 
is hemophilia? It is a hereditary disease which makes it so blood does 
not clot. Small wounds and punctures are usually not a problem, but 
larger wounds or uncontrolled internal bleeding can result in pain, 
swelling, permanent damage or even death.
  The CDC has a program, Prevention's Hereditary Blood Disorders. And 
it serves as the frontline for treatment for bleeding and clotting 
disorders with a national network of over 140 hemophilia treatment 
centers.
  Study after study has shown that these centers work extremely well. 
Mortality and morbidity rates have declined by 40 percent.
  Mr. Speaker, these hemophilia treatment centers are vital for 
patients and for the medical community. They have a strong record of 
success that has a foundation of over 30 years of experience, and it 
continues to grow every day. We need to do everything we can to make 
certain that Americans continue to receive this access to quality care.

                          ____________________